Epidemiology and the Department of Microbiology and Immunology of the University of North Carolina at Chapel Hill. During his early training, Dr. Baric was a Harvey Weaver Scholar for the National Multiple Sclerosis Society and an established investigator for the American Heart Association in association with his studies of coronavirus replication, cross-species transmission, persistence, evolution, and pathogenesis. He is a member of the Editorial Board of the Journal of Virology and a senior editor for PLoS Pathogens. Dr. Baric is a permanent member of a National Institutes of health (NIH) study section (VirB); has been a consultant for the World Health Organization, the Centers for Disease Control and Prevention, and NIH; and has served on various institutional recombinant-DNA review committees. He has published over 130 peer-reviewed manuscripts, including several in Science, the Proceedings of the National Academy of Sciences of the United States of America, and Nature Medicine, and his research efforts are supported by several NIH research grants. Dr. Baric’s expertise is primarily in norovirus molecular evolution and susceptibility and in coronavirus reverse genetics, synthetic genome reconstruction, pathogenesis, vaccine design, and cross-species transmission of viruses, often using the SARS coronavirus or noroviruses as models.

Dr. Roger G. Breeze received his veterinary degree in 1968 and his PhD in veterinary pathology in 1973, both from the University of Glasgow, Scotland. He was engaged in teaching, diagnostic pathology, and research on respiratory and cardiovascular diseases at the University of Glasgow Veterinary School from 1968 to 1977 and at Washington State University College of Veterinary Medicine from 1977 to 1987, where he was professor and chair of the Department of Microbiology and Pathology. From 1984 to 1987, he was deputy director of the Washington Technology Center, the state’s high-technology sciences initiative, based in the College of Engineering of the University of Washington. In 1987, he was appointed director of the U.S. Department of Agriculture (USDA) Plum Island Animal Disease Center, a Biosafety Level 3 facility for research and diagnosis related to the world’s most dangerous livestock diseases. In that role, he initiated research on the genomic and functional genomic basis of disease pathogenesis, diagnosis, and control of livestock RNA and DNA virus infections. That work became the basis of U.S. defense against natural and deliberate infection with those and led to his involvement in the early 1990s in biologic-weapons defense and proliferation prevention. From 1995 to 1998, Dr. Breeze directed research programs in 20 laboratories in the Southeast for the USDA Agricultural Research Service before going to Washington, D.C., to establish biologic-weapons defense research programs for USDA. He received the Distinguished Executive Award from President Clinton in 1998 for his work at Plum Island and in biodefense. Since 2004, he has been chief executive officer of Centaur Science Group, which provides consulting services in biodefense. His main commitment is to the Defense Threat Reduction Agency’s

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement